Larimar Therapeutics Inc. buy Quitte
Start price
04.10.16
/
50%
€37.88
Target price
31.01.17
€44.38
Performance (%)
17.14%
End price
31.01.17
€44.38
Summary
This prediction ended on 31.01.17 with a price of €44.38. The BUY prediction by Quitte finished with a performance of 17.14%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | -10.759% | -10.759% | 6.015% | 2.174% |
| iShares Core DAX® | 4,57 % | 3,43 % | 8,17 % | 58,38 % |
| iShares Nasdaq 100 | 1,83 % | -1,04 % | 34,66 % | 87,70 % |
| iShares Nikkei 225® | -0,29 % | 3,38 % | 61,85 % | 78,20 % |
| iShares S&P 500 | 2,23 % | 0,47 % | 25,07 % | 65,68 % |
Comments by Quitte for this prediction
In the thread Zafgen Inc. diskutieren